Use of Latanoprostene Bunod as Adjunctive Glaucoma Therapy in Refractory Glaucoma

AIM: To investigate the long-term efficacy of adjunctive use of latanoprostene bunod (LBN), a new nitric oxide donating prostaglandin medication, in refractory cases of glaucoma at a tertiary care center. MATERIALS AND METHODS: A review for patients who received add-on LBN was conducted from 1(st) J...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Benjamin, Bekerman, Vladislav P, Khouri, Albert S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905875/
https://www.ncbi.nlm.nih.gov/pubmed/36793262
http://dx.doi.org/10.5005/jp-journals-10078-1386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905875/
https://www.ncbi.nlm.nih.gov/pubmed/36793262
http://dx.doi.org/10.5005/jp-journals-10078-1386

Ejemplares similares